臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pei jer chen"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 496-520 / 883 (共36頁)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-07-03T03:34:17Z	Application of Massively Parallel Sequencing to Genetic Diagnosis in Multiplex Families with Idiopathic Sensorineural Hearing Impairment	Wu C.-C.; Lin Y.-H.; Lu Y.-C.; PEI-JER CHEN; Yang W.-S.; Hsu C.-J.; Chen P.-L.
臺大學術典藏	2021-07-03T03:34:17Z	Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence [2]	Yeh Y.-C.; PEI-JER CHEN; Lai M.-S.
臺大學術典藏	2021-07-03T03:34:17Z	Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection	Su T.-H.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen C.-L.; PEI-JER CHEN; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:16Z	Liver sinusoidal endothelial cell lectin inhibits CTL-dependent virus clearance in mouse models of viral hepatitis	Liu B.; Wang M.; Wang X.; Zhao D.; Liu D.; Liu J.; PEI-JER CHEN; Yang D.; He F.; Tang L.
臺大學術典藏	2021-07-03T03:34:16Z	Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant	Hsu H.-Y.; Chang M.-H.; Ni Y.-H.; Jeng Y.-M.; Chiang C.-L.; Chen H.-L.; Wu J.-F.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:16Z	Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice	Lin W.-H.; Yeh S.-H.; Yang W.-J.; Yeh K.-H.; Fujiwara T.; Nii A.; Chang S.S.-C.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:16Z	Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients	Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Liu C.-H.; Jeng J.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:15Z	Seroprevalence of Hepatitis E Virus Infection among Swine Farmers and the General Population in Rural Taiwan	Lee J.-T.; Shao P.-L.; Chang L.-Y.; Xia N.-S.; PEI-JER CHEN; Lu C.-Y.; Huang L.-M.
臺大學術典藏	2021-07-03T03:34:15Z	Polymerase chain reaction with phase change as intrinsic thermal control	Hsieh Y.-F.; Yonezawa E.; Kuo L.-S.; Yeh S.-H.; PEI-JER CHEN; Chen P.-H.
臺大學術典藏	2021-07-03T03:34:15Z	Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers	Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:15Z	Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C	Su T.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Ting T.-T.; Tseng T.-C.; PEI-JER CHEN; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:14Z	ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers	Liu W.-H.; Chen C.-H.; Yeh K.-H.; Li C.-L.; Wu Y.-J.; Chen D.-S.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏	2021-07-03T03:34:14Z	Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel	Cheng A.L.; Amarapurkar D.; Chao Y.; PEI-JER CHEN; Geschwind J.-F.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; Park J.-W.
臺大學術典藏	2021-07-03T03:34:14Z	Reduction of HBV replication prolongs the early immunological response to IFNα therapy	Tan A.T.; Hoang L.T.; Chin D.; Rasmussen E.; Lopatin U.; Hart S.; Bitter H.; Chu T.; Gruenbaum L.; Ravindran P.; Zhong H.; Gane E.; Lim S.G.; Chow W.C.; PEI-JER CHEN; Petric R.; Bertoletti A.; Hibberd M.L.
臺大學術典藏	2021-07-03T03:34:14Z	Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial	Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:13Z	SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma model	Tai W.-T.; Shiau C.-W.; Li Y.-S.; Chen Y.-L.; Chu P.-Y.; Huang J.-W.; Hsu C.-Y.; Hsu Y.-C.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:34:13Z	Eltrombopag increases platelet numbers in thrombocytopenic patients with hcv infection and cirrhosis, allowing for effective antiviral therapy	Afdhal N.H.; Dusheiko G.M.; Giannini E.G.; PEI-JER CHEN; Han K.-H.; Mohsin A.; Rodriguez-Torres M.; Rugina S.; Bakulin I.; Lawitz E.; Shiffman M.L.; Tayyab G.-U.-N.; Poordad F.; Kamel Y.M.; Brainsky A.; Geib J.; Vasey S.Y.; Patwardhan R.; Campbell F.M.; Theodore D.
臺大學術典藏	2021-07-03T03:34:12Z	Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection	Liu C.-J.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:12Z	Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma	Tai W.-T.; Shiau C.-W.; PEI-JER CHEN; Chu P.-Y.; Huang H.-P.; Liu C.-Y.; Huang J.-W.; Chen K.-F.
臺大學術典藏	2021-07-03T03:34:12Z	Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality	Liu C.-J.; Chu Y.-T.; Shau W.-Y.; Kuo R.N.; PEI-JER CHEN; Lai M.-S.
臺大學術典藏	2021-07-03T03:34:11Z	Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:11Z	Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin	Chen M.-Y.; Liu C.-H.; Chen T.-C.; Su T.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.; Liu C.-J.
臺大學術典藏	2021-07-03T03:34:11Z	Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy	Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:10Z	Reply	Hsu C.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:10Z	Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously	Cheng H.-R.; Kao J.-H.; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; Su T.-H.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.

顯示項目 496-520 / 883 (共36頁)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2822924
	造訪人次 : 30035983 線上人數 : 1216 教育部委託研究計畫計畫執行:國立臺灣大學圖書館